For the Inventor, By the Inventor

Enter assignee name

Laboratoires Upsa

USPTO Granted Patents = 22

Forward Citations = 358

Loading Chart...

Loading Chart...

19 inventors (with patents filed for the assignee):

Jean-Marie C Teulon (18 out of 40 patents)

Nicole Bru-Magniez (17 out of 28 patents)

Eric Nicolai (7 out of 18 patents)

4. Timur Gungor (6 out of 9 patents)

5. Michele Launay (5 out of 14 patents)

6. Dominique Potin (2 out of 11 patents)

7. Christian De Cock (2 out of 2 patents)

8. Jean-Luc De Keyser (2 out of 2 patents)

9. Jean-Francois S Cordoliani (2 out of 2 patents)

10. Jehan-Yves P Drouin (2 out of 3 patents)

11. Jacques H Poupaert (2 out of 4 patents)

12. Pierre A Dumont (2 out of 4 patents)

13. Alix Cloarec (1 out of 1 patent)

14. Francoise Camborde (1 out of 1 patent)

15. Eric Sartori (1 out of 3 patents)

22 patents: Sort by Forward Citations

1. 6015797 - Adenosinergic agonist containing pharmaceutical composition with (2000-01-18),

2. 6004994 - Heterocyclic diarylmethylene derivatives, methods of preparing them and (1999-12-21),

3. 5686460 - Carbocyclic diarylmethylene derivatives, processes for their preparation (1997-11-11),

4. 5663181 - Naphthyridine derivatives, their methods of preparation and (1997-09-02),

5. 5480983 - Adenosine derivatives, preparation methods and pharmaceutical (1996-01-02),

6. 5480652 - Effervescent pharmaceutical composition containing ibuprofen and its (1996-01-02),

7. 5459132 - N6-[(Imidazo[1,2-a]pyridin-3-yl)ethyl]adenosines, their 5'-uronamide (1995-10-17),

8. 5437874 - Pharmaceutical composition for the preparation of a stable powder (1995-08-01),

9. 5418242 - Piperidinylthioindole derivatives, their methods of preparation and (1995-05-23),

10. 5389632 - Pyrazolopyrimidine derivatives which are angiotensin II receptor (1995-02-14),

11. 5387747 - Triazolopyrimidine derivatives which are angiotensin II receptor (1995-02-07),

12. 5364860 - Naphthyridine compounds which inhibit tyrosine kinase and their (1994-11-15),

13. 5358950 - Triazolopyrimidine derivatives which are angiotensin II receptor (1994-10-25),

14. 5229505 - N.sup.6 -[3-(1-substituted)indolylethyl] adenosine 5'-carboxamides and (1993-07-20),

15. 5217973 - Triazolopyrimidine derivatives which are angiotensin II receptor (1993-06-08),

Laboratoires Upsa is a French pharmaceutical company specializing in the development and production of over-the-counter medications and healthcare products. With a history dating back over 80 years, Upsa is known for its commitment to innovation and high-quality products that are trusted by healthcare professionals and consumers worldwide.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

22 Patents

#1 in Agen

#919 in France

#27,863 in the World

Laboratoires Upsa

Forward Citations = 358

19 inventors:

Jean-Marie C Teulon (18 out of 40 patents)

Nicole Bru-Magniez (17 out of 28 patents)

Eric Nicolai (7 out of 18 patents)

4. Timur Gungor (6 out of 9 patents)

5. Michele Launay (5 out of 14 patents)

Please report any incorrect information to support@idiyas.com

Loading…